A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

• Status: Completed
• Trial end date: 2016-09-01

Summary

This study will be an open-label, randomized, three-period cross-over pharmacokinetic evaluation of CVT-301 compared with the Reference Listed Drug (RLD), orally administered carbidopa/levodopa, in healthy volunteers.

• Phase: Phase 1

Details

• Lead Sponsor: Acorda Therapeutics
• Treatments: Carbidopa; Carbidopa, levodopa drug combination; Levodopa